DSM Leads Sequencing of Aspergillus niger Genome

Jan 31, 2007

NEW YORK (GenomeWeb News) - Dutch industrial chemical firm DSM has completed a collaborative project to sequence the genome of Aspergillus niger CBS 513.88, a microorganism that DSM uses to produce enzymes and other compounds.

DSM and its collaborators are publishing the results of the sequencing project in the February issue of Nature Biotechnology. DSM said 29 other research institutions participated in the study.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

An RNAi Approval

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Keep It Going

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Stop It There

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

This Week in PLOS

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.

Featured White Papers

The Ultimate Guide to Mouse Clinical Trials

Sep

17

Featured Webinar

Trends in Clinical NGS QC Management: Expert Insights to Ensure Quality Results for Your Lab

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.

Main menu